Related Experiment Video
Updated: Jun 12, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
Published on: November 3, 2010
An association study on polymorphisms in the PEA15, ENTPD4, and GAS2L1 genes and schizophrenia
Atsushi Saito1, Yuta Fujikura-Ouchi, Chihiro Ito
1Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Japan. saito-at@dokkyomed.ac.jp
Abstract:
Our previous study examined a number of methamphetamine (METH)/phencyclidine (PCP)-reactive tags in rat brain, using a serial analysis of gene expression. Among human homologous genes, which matched METH/PCP-reactive tags, three human genes were identified: phosphoprotein enriched in astrocyte 15 (PEA15), ectonucleoside triphosphate diphosphohydrolase 4 (ENTPD4), and growth arrest-specific 2 like 1 (GAS2L1), which are localized in the chromosome 1q21.1, 8p21.3, and 22q12.2, respectively. We postulated that these genes are plausible candidate genes that play a role in pathogenesis for schizophrenia. Using tagging single-nucleotide polymorphisms (SNPs), we performed a case-control comparison for three SNPs in the PEA15 gene, and six SNPs in the GAS2L1 gene in a sample set of subjects (240 schizophrenia patients and 286 control subjects). Twelve SNPs in the ENTPD4 gene were analyzed in a subset of subjects (94 schizophrenia patients and 94 control subjects). No single SNP displayed a significant difference regarding the allelic frequency or genotypic distribution between the affected cases and controls for any of the genes examined. There was neither a significant difference in the frequency of three marker haplotype in the PEA15 gene or of six marker haplotype in the GAS2L1 gene between the cases and controls. The present study fails to provide evidence for the contribution of PEA15, ENTPD4, and GAS2L1 genes to the etiology of schizophrenia in the Japanese population.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
